Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5206020
Max Phase: Preclinical
Molecular Formula: C20H27N6NaO4
Molecular Weight: 416.48
Associated Items:
ID: ALA5206020
Max Phase: Preclinical
Molecular Formula: C20H27N6NaO4
Molecular Weight: 416.48
Associated Items:
Canonical SMILES: O=C([O-])CC(O)CNC(c1nnnn1CCCC(=O)NCc1ccccc1)C1CC1.[Na+]
Standard InChI: InChI=1S/C20H28N6O4.Na/c27-16(11-18(29)30)13-22-19(15-8-9-15)20-23-24-25-26(20)10-4-7-17(28)21-12-14-5-2-1-3-6-14;/h1-3,5-6,15-16,19,22,27H,4,7-13H2,(H,21,28)(H,29,30);/q;+1/p-1
Standard InChI Key: IOZYVGILZUUOKO-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 416.48 | Molecular Weight (Monoisotopic): 416.2172 | AlogP: 0.65 | #Rotatable Bonds: 13 |
Polar Surface Area: 142.26 | Molecular Species: ACID | HBA: 8 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.83 | CX Basic pKa: 7.64 | CX LogP: -2.26 | CX LogD: -2.43 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.37 | Np Likeness Score: -1.22 |
1. Ulgheri F, Spanu P, Deligia F, Loriga G, Fuggetta MP, de Haan I, Chandgudge A, Groves M, Domling A.. (2022) Design, synthesis and biological evaluation of 1,5-disubstituted α-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders., 229 [PMID:34823899] [10.1016/j.ejmech.2021.114002] |
Source(1):